The trademark Medisign was filed by Empecs Medical Device Co., Ltd., a corporation established under the laws of the Republic of Korea (the "Applicant"). The application was published for oppositions on May 10, 2020, and received one opposition filed on July 22, 2020 by Medesign Ingenieur-Consulting GmbH on Art. 8(4). the opponent was represented by PREU BOHLIG & PARTNER RECHTSANWÄLTE MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued July 22, 2020
The application was filed in Finnish, and Finnish was also language of all opposition proceedings (English was selected as the second language).
The Opposition with reference B 003126524 was rejected according to Article 8(4) EUTMR with decision issued on November 17, 2022 by the EUIPO.
Goods And Services
The mark was filed in class 5 with following description of goods:
Test strips for measuring blood glucose level
Reagents for measuring blood glucose level
Test strips for detecting glycated hemoglobin level in blood
Reagents for detecting glycated hemoglobin level in blood
Reagents for in vitro medical diagnosis
Medical diagnosis reagents for the analysis of body fluids
Medical diagnostic test strips for blood analysis
Medical diagnostic test strips for the analysis of body fluids.
The mark was filed in class 10 with following description of goods:
Medical diagnostic devices for measuring blood glucose level, namely, blood glucose meters
Apparatuses for detecting glycated hemoglobin level in blood
Apparatuses for blood analysis
Medical diagnostic instruments for analysis of body fluids
Devices for measuring blood sugar for medical purposes
Blood ketone measuring instruments for medical purposes
Blood uric acid measuring instruments for medical purposes
Blood cholesterol measuring instruments for medical purposes
Apparatus for blood monitoring cartridges for medical purposes.